journal cover

The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA

Annals of the Rheumatic Diseases

Jan 1, 2014

Jakub ZávadaBritish Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium

Get paper from

Abstract

To evaluate the risk of gastrointestinal perforation (GIP) in subjects with rheumatoid arthritis (RA) treated with antitumour necrosis factor (anti-TNF) therapy compared with non-biological disease-modifying antirheumatic drugs (nbDMARDs). Using data from the British Society for Rheumat...read more

Mentioned in this Paper

Biological Products
Rheumatology Specialty
Gastrointestinal Diseases
Gastrointestinal Perforation
Intestinal Perforation
Steroids
Immunosuppressive Agents
Tumor Necrosis Factor-alpha
Cox Proportional Hazards Models
Necrosis
11
30
Paper Details
References
  • References11
  • Citations6
12

The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA

Annals of the Rheumatic Diseases

Jan 1, 2014

Jakub ZávadaBritish Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium

PMID: 23644671

DOI: 10.1136/annrheumdis-2012-203102

Abstract

To evaluate the risk of gastrointestinal perforation (GIP) in subjects with rheumatoid arthritis (RA) treated with antitumour necrosis factor (anti-TNF) therapy compared with non-biological disease-modifying antirheumatic drugs (nbDMARDs). Using data from the British Society for Rheumat...read more

Mentioned in this Paper

Biological Products
Rheumatology Specialty
Gastrointestinal Diseases
Gastrointestinal Perforation
Intestinal Perforation
11
30

Related Papers

Paper Details
References
  • References11
  • Citations6
12

Get paper from

/papers/the-risk-of-gastrointestinal-perforations-in/23644671